Hope
Our Mission Statement
We are dedicated to improving the health of women through education on the warning signs of ovarian cancer, support of those diagnosed with the disease and promotion of ovarian cancer research.
Learn More
Know the Signs
Ovarian cancer is difficult to detect, especially in the early stages. Do you know the signs?
Learn More
Recent News from Ovarian Cancer Research Fund Alliance
- National Comprehensive Cancer Network Updates Guidelines 03/26/2019(March 26, 2019) The NCCN, or the National Comprehensive Cancer Network, recently updated its clinical guidelines for the treatment of ovarian cancers. The guidelines, a summary of which can be found here, have been updated after several studies were completed and the FDA approved several new drugs. The new guidelines address topics such as PARP… […]
- OCRA Funded Study Aims to Increase Efficacy of PARP Inhibitors 03/20/2019(March 20, 2019) The Ovarian Cancer Dream Team, funded in part by OCRA, recently completed a Phase 1b Trial, which combined a PARP inhibitor with an HRR (homologous recombination repair) pathway inhibitor, such as PI3K, in order to increase the efficacy of PARP inhibitors in breast and epithelial ovarian cancers. Phase 1 trials are used… […]
